Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, proteostasis deficienciesActive, not recruitingNot stated2026-07-29NCT07062848

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Bridgebio Pharma, Inc2
Yale University458

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Henry Ford HealthDetroitUnited States75
Houstin MethodistHoustonUnited States1
Medical University of South Carolina (MUSC) HealthCharlestonUnited States1
MontefioreThe BronxUnited States7
Mount SinaiNew YorkUnited States58
Providence HealthTigardUnited States1
The University of ChicagoChicagoUnited States65
University of California - San Francisco (UCSF) HealthSan FranciscoUnited States1
University of Virginia School of MedicineCharlottesvilleUnited States6
University of Washington MedicineSeattleUnited States4
UT Southwestern Medical CenterDallasUnited States210
Yale New Haven Health SystemNew HavenUnited States4